Porth Ymchwil

Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. / Oscarsson, K.; Lahmann, M.; Lindberg, J. et al.
Yn: Bioorganic and Medicinal Chemistry, Cyfrol 11, Rhif 6, 20.03.2003, t. 1107-1115.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Oscarsson, K, Lahmann, M, Lindberg, J, Kangasmetsa, J, Unge, T, Oscarson, S, Hallberg, A & Samuelsson, B 2003, 'Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex', Bioorganic and Medicinal Chemistry, cyfrol. 11, rhif 6, tt. 1107-1115. https://doi.org/10.1016/S0968-0896(02)00535-7

APA

Oscarsson, K., Lahmann, M., Lindberg, J., Kangasmetsa, J., Unge, T., Oscarson, S., Hallberg, A., & Samuelsson, B. (2003). Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. Bioorganic and Medicinal Chemistry, 11(6), 1107-1115. https://doi.org/10.1016/S0968-0896(02)00535-7

CBE

Oscarsson K, Lahmann M, Lindberg J, Kangasmetsa J, Unge T, Oscarson S, Hallberg A, Samuelsson B. 2003. Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. Bioorganic and Medicinal Chemistry. 11(6):1107-1115. https://doi.org/10.1016/S0968-0896(02)00535-7

MLA

Oscarsson, K. et al. "Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex". Bioorganic and Medicinal Chemistry. 2003, 11(6). 1107-1115. https://doi.org/10.1016/S0968-0896(02)00535-7

VancouverVancouver

Oscarsson K, Lahmann M, Lindberg J, Kangasmetsa J, Unge T, Oscarson S et al. Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. Bioorganic and Medicinal Chemistry. 2003 Maw 20;11(6):1107-1115. doi: 10.1016/S0968-0896(02)00535-7

Author

Oscarsson, K. ; Lahmann, M. ; Lindberg, J. et al. / Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex. Yn: Bioorganic and Medicinal Chemistry. 2003 ; Cyfrol 11, Rhif 6. tt. 1107-1115.

RIS

TY - JOUR

T1 - Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2 '-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex

AU - Oscarsson, K.

AU - Lahmann, M.

AU - Lindberg, J.

AU - Kangasmetsa, J.

AU - Unge, T.

AU - Oscarson, S.

AU - Hallberg, A.

AU - Samuelsson, B.

PY - 2003/3/20

Y1 - 2003/3/20

KW - BIOCHEMISTRY & MOLECULAR BIOLOGY

KW - CHEMISTRY

KW - MEDICINAL

KW - ORGANIC

U2 - 10.1016/S0968-0896(02)00535-7

DO - 10.1016/S0968-0896(02)00535-7

M3 - Article

VL - 11

SP - 1107

EP - 1115

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 6

ER -